Blue Horseshoe Stocks: PRGO Recap & More


Perrigo Co. plc PRGO

We placed a number of options ideas on watch yesterday, and PRGO produced the biggest gainer of the day, even as the markets as a whole continued to be in distress.

Despite posting a loss, the company’s earnings beat expectations and after a huge gap-up to start the day, the stock traded with sufficient intraday volatility to provide a nice opportunity for single-session profits in the PRGO Weekly $75 Calls.

Those contracts traded in a range from a low of .15 up to an impressive high of 2.50, marking an enormous 1566% rip on the day.



Nvidia Corp. NVDA

We’re seeing NVIDIA taking a hit in the premarket this morning, even as it just received a price target upgrade from analysts on the heel of its own earnings report.

We see the possibility of a rebound for NVDA stock leading to some nice activity for the NVDA 09/01 $155 and $157.50′s Calls , so those are the contracts we’ll place on watch today.


Extended Watchlist:
TOPS, SHIP, DCIX GLBS, ANW, ETRM, DEWM

Blue Horseshoe Stocks: BBRY Recap & More

Cumulus Media, Inc. CMLS

We’re looking at CMLS as a possible momentum play. The stock has been building up quite a head of steam over the past few sessions, trading an inordinately high amount of volume yesterday.

Since hitting its lows toward the end of last month the stock has been in a general uptrend. Every time it has receded, it has rebounded back to set new highs. We’ll place CMLS on watch to see if it can maintain the powerful trend it has established.

CMLS is gapping up in the premarket this morning. On any pullbacks, we’ll want to see CMLS maintain support at a minimum of .50 in order to maintain our immediate interest.



BlackBerry Ltd. BBRY

Normally, when we alert on a big board play without including some type of options idea, as we did with BBRY back on March 31st (and April 12th), it’s because we feel the stock itself is generally undervalued. Where BlackBerry is concerned, we have thus far turned out to be right on the money. We saw a low of 7.47 on the morning of March 31st, and BBRY hasn’t looked back since.

In its largest single session move of the year, the stock hit 11.38 yesterday. That represents an increase of 52% over our observed low, as we’ve pointed out on the chart below. .

____

FerroGlobe PLC (GSM) – Along the same lines, we highlighted GSM yesterday, a stock which is priced similarly to BBRY. It managed a slight increase after gapping up, and we’re going to continue watching this one as well.


Extended Watchlist:
PGPM, HMNY, ETRM, RGSE, PLX, BPMX, FRTA(Bottom watch)

Blue Horseshoe Stocks: SNDX Recap, Options & More

Syndax Pharmaceuticals, Inc. SNDX

Despite the markets getting crushed yesterday we managed to find and tag in our premarket report, what would ultimately be the NASDAQ’s top gainer of the day. SNDX had been gradually coming up off a bottom in the few sessions prior, but yesterday things really kicked into gear.

It traded in a range from 10.76 to 15.335, a fantastic intraday move of 43% which is really impressive for a $10+ stock. That move inside of the first 90 minutes of the session. That was followed by a dip-and-rip pattern from 12.16 and back to 13.62; a 12% rebound into a strong close at 13.58

The stock traded 56x its 30-day average volume yesterday, and held more than half of its daily advance, so we’ll be treating this as a potential momentum play as we head into week’s end, looking out for higher highs and higher lows out of SNDX.


Fresh Options Ideas

Speaking of the markets getting crushed, it appears as if we may see a continuation of that pattern today, so we want to have a few sets of options ideas to fall back on in the event of a continued slide.

Alibaba Group Holding Ltd. BABA – BABA had been on an incredible bullish run for the better of part of 2017 thus far as you can plainly see on the chart snapshot we’ve included here. You can also see that the strength index is sharply declining after having recently been indicating the stock was extremely overbought.  We can also see the MACD pinching toward a bearish cross.

That’s why, along with an earnings miss in the premarket and the overall current of the markets as a whole, we’re looking at the BABA Weekly $120-117 Puts for potential quick-strike swing trades.


____

SPDR S&P 500 ETF Trust (SPY)  – Also in the vein of our general bearish view of today’s overall conditions, we want to line up a set of SPY Puts for observation. Our regular readers know that the SPY is one of our favorite market analogs, and has been a wellspring of gains for us on the options front when we correctly gauge investor sentiment.

Today we want to put the SPY Weekly $237-235 Puts on watch, as a sustained tumultuous period for stocks would likely produce some good chances for us there.


Extended Watchlist:
P, GLYC, CYTR, ETRM, XGTI, VSLR

Blue Horseshoe Stocks: Potential Bottom-Plays & More

 Bottom-Watch Plays

We want to start things off this morning by highlighting a couple of stocks on the higher exchanges that are both currently trading at a low multiple. Stocks that trade on the NASDAQ and NYSE at less than a dollar per share for at least a month can face de-listing procedures, so companies in danger of this tend to go to great lengths to buoy their stock price.

We’re always on the lookout for possible bottom plays so we’re going to be tracking both of the following in coming sessions.

Cobalt International Energy, Inc. CIE – The de-listing alarm bells haven’t quite gone off yet at with CIE, as the PPS just fell below a buck toward the end of last month. The stock also has a recent track record of brief periods of sub-1.00 trading from which it has promptly recovered each time.

This leads us to believe that the company may not even get to the point of receiving a notice from the NYSE before share price sees a recovery. We’re going to want to be on the lookout for that potential rebound.

______

Alliqua Biomedical, Inc. ALQA – In the case of ALQA, a NASDAQ play, the situation is a bit more pressing. Shares fell below the dollar mark at the beginning of September, and the company did receive its ‘failure to satisfy listing requirement’ notice back in October. The PPS has lagged ever since, and has only until the end of April to re-attain the dollar mark, or face delisting.

We’ll be interested to follow along to see what efforts are untaken to once again satisfy listing requirements. In the meantime, the stock has found a reasonably solid base of support off of recent lows, so we’ll be on the lookout for possible rebounds.


Viacom, Inc. VIAB – Options Idea

Our regular readers know full well that we love a good earnings-related options idea, and that’s what we’ve got this morning with Viacom. The company just posted an impressive earnings beat, along with strategic guidance updates that has the stock rocking in the premarket.

We’re going to be keeping our eyes open upon the opening bell, and tracking the activity in the VIAB Weekly $44-45.50 Calls.


Extended Watchlist:
MMEG, SDVI, ISBG, ETRM, CLF, TSLA,

Blue Horseshoe Stocks: Pharma News Watchlist & More

Pharma News Watchlist:

We’ve got a trio of pharma plays to add to our watchlist on the heels of fresh news releases for each of them this morning. Each stock is gapping up significantly in the premarket, and we’ll be waiting in the wings once the session commences to see if we can use the resulting activity to our advantage.

Akebia Therapeutics, Inc. AKBA – Per the newly announced agreement out today, AKBA has entered into a Collaboration and License Agreement to carry forward with the development of one of its treatments. The deal comes with an immediate payment of $125M, a cash infusion that represents roughly 40% of the company’s total market cap as of yesterday.

______

ACADIA Pharmaceuticals, Inc. ACAD – In the case of ACAD, we’ve gotten word of positive top-line results in a Phase II study it was conducting on the company’s Alzheimer’s drug.  To leverage the present activity to our advantage here, we’re going to track the ACAD Weekly $28-31 Calls. (>>View PR)

_______

Conatus Pharmaceuticals, Inc. CNAT

Here we have another collaboration and licensing deal, for CNAT’s liver drug, which is going to be bringing a $50M cash infusion Conatus’ way. That’s just the initial tranche, with more payments to follow as outlined in the relevant filing (>>View 8-K)


Globalstar, Inc. GSAT

We put GSAT on watch as a possible momentum play in yesterday morning’s premarket report, and while it didn’t break out in a major way, it did continue the trend of solid upward momentum that has been observed in recent sessions. From an early low of 1.25, the stock ran as high as 1.60; a 28% pop.

The performance, while not astronomical, was certainly enough to hold our interest in continuing to monitor GSAT’s activity moving forward.


Cellectar Biosciences, Inc. CLRB – Reminder

We just wanted to take a quick moment to reiterate a possible bottom-play selection we made last week in the form of CLRB. We’re still tracking this one, and think it has a good chance to produce a recovery, possibly following the holiday break. So we’re going to want to leave a space on our watch screens reserved for CLRB in the days and weeks ahead.


Extended Watchlist:
AXPW, CAPS, MFST, ENDV, ETRM, EXAD